About this FactMed analysis covering adverse side effect reports of ALFENTANIL patients who developed DIARRHOEA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking ALFENTANIL reported DIARRHOEA to the FDA. A total of 427 ALFENTANIL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALFENTANIL and DIARRHOEA. In doing so, we compare ALFENTANIL with other drugs that cause DIARRHOEA, to help you evaluate whether or not ALFENTANIL causes DIARRHOEA. Likewise, this page shows the most highly-reported side effects of ALFENTANIL, so you can see if DIARRHOEA ranks among ALFENTANIL's most well-known side effects.
Summary Statistics
Reports of ALFENTANIL causing DIARRHOEA: 2
Reports of any side effect of ALFENTANIL : 427
Percentage of ALFENTANIL patients where DIARRHOEA is a reported side effect: 0.4684%

FDA reports of any drug causing DIARRHOEA : 123783
Average percentage for all medicated patients where DIARRHOEA is reported as a complication: 0.7758%

Physician opinion on ALFENTANIL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALFENTANIL:
ANAESTHESIA ( 63 patients )
GENERAL ANAESTHESIA ( 52 patients )
SEDATION ( 17 patients )
DRUG USE FOR UNKNOWN INDICATION ( 16 patients )
INDUCTION OF ANAESTHESIA ( 16 patients )
OSTEOTOMY ( 15 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 13 patients )
PAIN ( 6 patients )
SENSORY DISTURBANCE ( 5 patients )
DRUG ABUSE ( 4 patients )
ANAESTHESIA PROCEDURE ( 3 patients )
IN VITRO FERTILISATION ( 3 patients )
DRUG WITHDRAWAL SYNDROME ( 2 patients )
ILL-DEFINED DISORDER ( 2 patients )
MUSCLE RELAXANT THERAPY ( 1 patients )
PNEUMONIA ( 1 patients )
DISCOMFORT ( 1 patients )
SURGERY ( 1 patients )
LIGHT ANAESTHESIA ( 1 patients )
PERIOPERATIVE ANALGESIA ( 1 patients )
POST PROCEDURAL PAIN ( 1 patients )
COLONOSCOPY ( 1 patients )
RETINAL DETACHMENT ( 1 patients )
VARICOSE VEIN OPERATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with DIARRHOEA:

ASPIRIN (8825 patients)
FOSAMAX (6626 patients)
HUMIRA (5790 patients)
SANDOSTATIN LAR (5337 patients)
NEXAVAR (4595 patients)
NEXIUM (4468 patients)
PREDNISONE (4401 patients)
LASIX (4335 patients)
LISINOPRIL (4076 patients)
LIPITOR (4061 patients)
HEPARIN SODIUM INJECTION (3985 patients)
OMEPRAZOLE (3884 patients)
SYNTHROID (3699 patients)
VIOXX (3665 patients)
METFORMIN HCL (3603 patients)
BYETTA (3578 patients)
EXJADE (3553 patients)
XELODA (3384 patients)
FLUOROURACIL (3286 patients)
METHOTREXATE (3275 patients)
ZOMETA (3124 patients)
REMICADE (3063 patients)
FOLIC ACID (3058 patients)
ATENOLOL (3014 patients)
FUROSEMIDE (2965 patients)
SIMVASTATIN (2942 patients)
DEXAMETHASONE (2806 patients)
COUMADIN (2790 patients)
ENBREL (2737 patients)
ACETAMINOPHEN (2691 patients)
REVLIMID (2646 patients)
PRILOSEC (2644 patients)
HYDROCHLOROTHIAZIDE (2606 patients)
CAPECITABINE (2587 patients)
XANAX (2520 patients)
FORTEO (2455 patients)
ZOLOFT (2430 patients)
PLAVIX (2382 patients)
LEVOTHYROXINE SODIUM (2367 patients)
NORVASC (2357 patients)
TYKERB (2339 patients)
PROTONIX (2338 patients)
ALLOPURINOL (2334 patients)
OXALIPLATIN (2295 patients)
NEURONTIN (2294 patients)
PREDNISOLONE (2287 patients)
DIGOXIN (2284 patients)
VITAMIN D (2277 patients)
LYRICA (2239 patients)
POTASSIUM CHLORIDE (2229 patients)
TOPROL-XL (2214 patients)
AMBIEN (2189 patients)
SEROQUEL (2155 patients)
OXYCONTIN (2143 patients)
CISPLATIN (2080 patients)
CYMBALTA (2067 patients)
ZOFRAN (2060 patients)
LORAZEPAM (2056 patients)
PREVACID (1990 patients)
PAXIL (1988 patients)
ZOCOR (1982 patients)
CELEBREX (1967 patients)
ATIVAN (1937 patients)
LEXAPRO (1911 patients)
ALBUTEROL (1828 patients)
CRESTOR (1818 patients)
IBUPROFEN (1796 patients)
CHANTIX (1795 patients)
PREDNISONE TAB (1769 patients)
VELCADE (1758 patients)
DECADRON (1745 patients)
DIOVAN (1722 patients)
LANTUS (1712 patients)
CYCLOPHOSPHAMIDE (1702 patients)
CALCIUM (1700 patients)
GABAPENTIN (1693 patients)
CARBOPLATIN (1685 patients)
AREDIA (1673 patients)
GLUCOPHAGE (1645 patients)
VICODIN (1641 patients)
METOPROLOL TARTRATE (1627 patients)
GLEEVEC (1619 patients)
LEVAQUIN (1554 patients)
TYSABRI (1552 patients)
AVONEX (1538 patients)
AMLODIPINE (1538 patients)
WARFARIN SODIUM (1536 patients)
PERCOCET (1524 patients)
RIBAVIRIN (1522 patients)
YAZ (1518 patients)
AVASTIN (1485 patients)
OXYCODONE HCL (1458 patients)
IMODIUM (1449 patients)
NIASPAN (1431 patients)
MULTI-VITAMINS (1425 patients)
SUTENT (1416 patients)
YASMIN (1407 patients)
MULTI-VITAMIN (1394 patients)
CLONAZEPAM (1366 patients)
ZANTAC (1335 patients)
LANSOPRAZOLE (1331 patients)
INSULIN (1330 patients)
DOCETAXEL (1325 patients)
PREMARIN (1309 patients)
MORPHINE (1291 patients)
PEGASYS (1282 patients)
EFFEXOR (1270 patients)
LEUCOVORIN CALCIUM (1257 patients)
ALLI (1255 patients)
MYCOPHENOLATE MOFETIL (1252 patients)
ADVAIR DISKUS 100/50 (1236 patients)
TYLENOL (CAPLET) (1232 patients)
PROZAC (1230 patients)
TRAMADOL HCL (1223 patients)
BONIVA (1211 patients)
ALPRAZOLAM (1209 patients)
AMOXICILLIN (1202 patients)
CYCLOSPORINE (1199 patients)
ACTOS (1197 patients)
COREG (1193 patients)
METFORMIN (1191 patients)
IRINOTECAN HCL (1179 patients)
COMPAZINE (1170 patients)
BEVACIZUMAB (1166 patients)
TAXOTERE (1164 patients)
KLONOPIN (1159 patients)
VICTOZA (1151 patients)
RAMIPRIL (1145 patients)
TACROLIMUS (1116 patients)
FLUCONAZOLE (1115 patients)
ACYCLOVIR (1111 patients)
METOPROLOL (1104 patients)
DURAGESIC-100 (1103 patients)
SPIRONOLACTONE (1099 patients)
VITAMIN B-12 (1092 patients)
SINGULAIR (1087 patients)
CIPROFLOXACIN (1074 patients)
BACTRIM (1063 patients)
PROGRAF (1056 patients)
ACCUTANE (1053 patients)
GLIPIZIDE (1045 patients)
CALCIUM CARBONATE (1045 patients)
COZAAR (1042 patients)
ASCORBIC ACID (1038 patients)
PRADAXA (1028 patients)
AVELOX (1018 patients)
RANITIDINE (1010 patients)
WELLBUTRIN (1008 patients)
CELEXA (1001 patients)
PACLITAXEL (1001 patients)
SPIRIVA (991 patients)
DIAZEPAM (987 patients)
ENALAPRIL MALEATE (986 patients)
FISH OIL (985 patients)
LAPATINIB (982 patients)
BENADRYL (972 patients)
ACTONEL (972 patients)
LOMOTIL (971 patients)
TRAZODONE HCL (963 patients)
ZYRTEC (960 patients)
LORTAB (950 patients)
NITROGLYCERIN (950 patients)
KALETRA (942 patients)
VANCOMYCIN (931 patients)
PANTOPRAZOLE (926 patients)
METOCLOPRAMIDE (926 patients)
TYLENOL (920 patients)
ONDANSETRON (912 patients)
VALIUM (910 patients)
FENTANYL (909 patients)
CIMZIA (908 patients)
GLYBURIDE (906 patients)
IRESSA (902 patients)
FLAGYL (899 patients)
AVANDIA (890 patients)
ARANESP (888 patients)
AMARYL (885 patients)
ALLEGRA (884 patients)
ALDACTONE (884 patients)
AUGMENTIN '125' (883 patients)
TARCEVA (880 patients)
FERROUS SULFATE TAB (871 patients)
NEUPOGEN (870 patients)
LOVENOX (869 patients)
HERCEPTIN (859 patients)
ZITHROMAX (859 patients)
ZELNORM (857 patients)
LOPRESSOR (840 patients)
TAXOL (839 patients)
FAMOTIDINE (839 patients)
MORPHINE SULFATE (832 patients)
VITAMIN E (828 patients)
REGLAN (827 patients)
ALTACE (814 patients)
ZETIA (814 patients)
PEPCID (806 patients)
DIFLUCAN (806 patients)
CITALOPRAM HYDROBROMIDE (801 patients)
CETUXIMAB (801 patients)
DOXORUBICIN HCL (796 patients)
NEORAL (795 patients)
ALENDRONATE SODIUM (790 patients)
SOLIRIS (789 patients)
DILAUDID (786 patients)
ERLOTINIB HYDROCHLORIDE (778 patients)
PANTOPRAZOLE SODIUM (772 patients)
AMITRIPTYLINE HCL (770 patients)
IRON (768 patients)
NAPROXEN (767 patients)
FLEXERIL (766 patients)
Most common side effects for patients taking ALFENTANIL:
DRUG INTERACTION (75 patients)
DYSTONIA (56 patients)
MYOTONIA (54 patients)
RENAL IMPAIRMENT (42 patients)
SINUS TACHYCARDIA (34 patients)
AGITATION (32 patients)
BACK PAIN (28 patients)
TOXIC EPIDERMAL NECROLYSIS (28 patients)
INFECTION (26 patients)
CARDIAC ARREST (26 patients)
DRUG WITHDRAWAL SYNDROME (26 patients)
THERAPEUTIC AGENT TOXICITY (24 patients)
DRUG EFFECT DECREASED (24 patients)
BRADYCARDIA (23 patients)
TACHYCARDIA (19 patients)
MYOCLONUS (19 patients)
STARING (19 patients)
ANAPHYLACTIC SHOCK (18 patients)
HYPOTENSION (18 patients)
DRUG TOXICITY (18 patients)
MULTI-ORGAN FAILURE (17 patients)
VENTRICULAR FIBRILLATION (16 patients)
BRONCHOSPASM (16 patients)
DEATH (16 patients)
ALANINE AMINOTRANSFERASE INCREASED (15 patients)
OXYGEN SATURATION DECREASED (15 patients)
DRUG EXPOSURE DURING PREGNANCY (15 patients)
HEPATITIS (15 patients)
RESTLESSNESS (14 patients)
PANIC REACTION (14 patients)
LIVER FUNCTION TEST ABNORMAL (14 patients)
ABDOMINAL PAIN (13 patients)
WHITE BLOOD CELL COUNT INCREASED (13 patients)
TUBULOINTERSTITIAL NEPHRITIS (13 patients)
DRUG INEFFECTIVE (13 patients)
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (13 patients)
ANAPHYLACTIC REACTION (12 patients)
HYPERHIDROSIS (12 patients)
NAUSEA (12 patients)
RENAL FAILURE ACUTE (12 patients)
GASTROINTESTINAL HAEMORRHAGE (12 patients)
OEDEMA PERIPHERAL (12 patients)
AGGRESSION (11 patients)
COMA (11 patients)
CYANOSIS (11 patients)
ESCHERICHIA INFECTION (11 patients)
SOMNOLENCE (11 patients)
HAEMOGLOBIN DECREASED (11 patients)
PLEURAL EFFUSION (10 patients)
BLOOD PHOSPHORUS INCREASED (10 patients)
HYPERVENTILATION (10 patients)
CONDITION AGGRAVATED (10 patients)
DISEASE PROGRESSION (10 patients)
HYPOXIA (10 patients)
FEELING ABNORMAL (10 patients)
PULMONARY OEDEMA (9 patients)
SPEECH DISORDER (9 patients)
MYALGIA (9 patients)
ATRIAL FIBRILLATION (9 patients)
PILOERECTION (9 patients)
CAESAREAN SECTION (9 patients)
SEROTONIN SYNDROME (9 patients)
CATATONIA (9 patients)
POST PROCEDURAL COMPLICATION (9 patients)
DYSPNOEA (9 patients)
MYDRIASIS (9 patients)
HEPATIC FAILURE (9 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (8 patients)
AKATHISIA (8 patients)
ANAESTHETIC COMPLICATION (8 patients)
LACERATION (8 patients)
BLOOD ALBUMIN DECREASED (8 patients)
BLOOD BILIRUBIN INCREASED (8 patients)
BLOOD CALCIUM INCREASED (8 patients)
BRAIN OEDEMA (8 patients)
PNEUMONIA (8 patients)
PUPILLARY REFLEX IMPAIRED (8 patients)
ELECTROCARDIOGRAM QT PROLONGED (8 patients)
RHABDOMYOLYSIS (8 patients)
BLISTER (7 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (7 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (7 patients)
HYPERSENSITIVITY (7 patients)
PYREXIA (7 patients)
C-REACTIVE PROTEIN INCREASED (7 patients)
PARAESTHESIA (7 patients)
VOMITING (7 patients)
PREMATURE RUPTURE OF MEMBRANES (7 patients)
SCLERODERMA (7 patients)
RENAL FAILURE (7 patients)
EXTENSOR PLANTAR RESPONSE (7 patients)
FATIGUE (7 patients)
HAEMATEMESIS (7 patients)
SLEEP DISORDER (7 patients)
PREMATURE LABOUR (7 patients)
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED (6 patients)
AMNESIA (6 patients)
PEMPHIGOID (6 patients)
PROCEDURAL COMPLICATION (6 patients)
ASCITES INFECTION (6 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (6 patients)
HYPOCOAGULABLE STATE (6 patients)
BLOOD PRESSURE DECREASED (6 patients)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (6 patients)
VENTRICULAR TACHYCARDIA (6 patients)
HYPERGLYCAEMIA (6 patients)
WOUND SECRETION (6 patients)
ENTEROCOCCAL INFECTION (6 patients)
MOVEMENT DISORDER (6 patients)
SEPSIS (6 patients)
NO THERAPEUTIC RESPONSE (6 patients)
GLASGOW COMA SCALE ABNORMAL (6 patients)
ABDOMINAL SEPSIS (5 patients)
HYPOTONIA (5 patients)
HYPERREFLEXIA (5 patients)
APHASIA (5 patients)
ASCITES (5 patients)
HYPERPARATHYROIDISM (5 patients)
HYPOKALAEMIA (5 patients)
CARDIO-RESPIRATORY ARREST (5 patients)
UNRESPONSIVE TO STIMULI (5 patients)
THROMBOCYTOPENIA (5 patients)
PROPOFOL INFUSION SYNDROME (5 patients)
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION (5 patients)
SCREAMING (5 patients)
ISCHAEMIC STROKE (5 patients)
FALL (5 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (5 patients)
TREMOR (5 patients)
HEMIPLEGIA (5 patients)
SMALL INTESTINAL HAEMORRHAGE (5 patients)
NEUTROPENIA (4 patients)
ACCIDENTAL OVERDOSE (4 patients)
RESUSCITATION (4 patients)
AIRWAY COMPLICATION OF ANAESTHESIA (4 patients)
TRANSAMINASES INCREASED (4 patients)
ARRHYTHMIA (4 patients)
ARTHRALGIA (4 patients)
NO ADVERSE EVENT (4 patients)
BLOOD TRIGLYCERIDES INCREASED (4 patients)
INJURY (4 patients)
MATERNAL DRUGS AFFECTING FOETUS (4 patients)
RESPIRATORY DEPRESSION (4 patients)
MOTOR DYSFUNCTION (4 patients)
MUSCLE RIGIDITY (4 patients)
LABILE BLOOD PRESSURE (4 patients)
CELLULITIS (4 patients)
DELAYED RECOVERY FROM ANAESTHESIA (4 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (4 patients)
HYPERTENSION (4 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (4 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (4 patients)
PULMONARY EMBOLISM (4 patients)
ECTOPIC PREGNANCY (4 patients)
RASH ERYTHEMATOUS (4 patients)
MELAENA (4 patients)
FOETAL MALPRESENTATION (4 patients)
NEUTROPHILIA (4 patients)
GRAND MAL CONVULSION (4 patients)
SUBARACHNOID HAEMORRHAGE (4 patients)
OEDEMA (4 patients)
ABORTION INDUCED (3 patients)
ANHEDONIA (3 patients)
VARICOSE VEIN OPERATION (3 patients)
PAIN (3 patients)
ANXIETY (3 patients)
APALLIC SYNDROME (3 patients)
MICROSTOMIA (3 patients)
RESPIRATORY FAILURE (3 patients)
BLOOD CREATININE INCREASED (3 patients)
UNEVALUABLE EVENT (3 patients)
PANIC ATTACK (3 patients)
BLOOD POTASSIUM DECREASED (3 patients)
BONE DISORDER (3 patients)
BRAIN DEATH (3 patients)
CARDIAC DISORDER (3 patients)
METABOLIC ACIDOSIS (3 patients)
SKIN REACTION (3 patients)
PANCREATIC ABSCESS (3 patients)
CEREBRAL HAEMORRHAGE (3 patients)
CEREBRAL ISCHAEMIA (3 patients)
CEREBROVASCULAR ACCIDENT (3 patients)
CHOLESTASIS (3 patients)
ORGAN FAILURE (3 patients)
PANCREATITIS (3 patients)
CONVULSION (3 patients)
CYTOLYTIC HEPATITIS (3 patients)
TUMOUR LYSIS SYNDROME (3 patients)
PANCREATIC NECROSIS (3 patients)
DEHYDRATION (3 patients)
DEPRESSION (3 patients)
PROTHROMBIN TIME PROLONGED (3 patients)
DRUG HYPERSENSITIVITY (3 patients)
HYPOGLYCAEMIA NEONATAL (3 patients)
DYSPHASIA (3 patients)
DYSPHONIA (3 patients)
RENAL INJURY (3 patients)
LOCALISED OEDEMA (3 patients)
ELECTROMECHANICAL DISSOCIATION (3 patients)
RAYNAUD'S PHENOMENON (3 patients)
ERYTHEMA (3 patients)
FACE OEDEMA (3 patients)
FEAR (3 patients)
SEX CHROMOSOME ABNORMALITY (3 patients)
SKIN DISCOLOURATION (3 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (3 patients)
HAEMATOMA (3 patients)
HAEMODIALYSIS (3 patients)
THERAPY NON-RESPONDER (3 patients)
HEART RATE INCREASED (3 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALFENTANIL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about DIARRHOEA and ALFENTANIL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question: